Teva announces U.S. launch of generic version of VESIcare
Teva Pharmaceutical Industries announced the launch of a generic version of VESIcare Tablets, 5 mg and 10 mg, in the U.S. Solifenacin Succinate Tablets are indicated for the treatment of overactive bladder.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.